What % cut on sales would you expect Starpharma to receive from Aspen and any other partners in the near future.
Given we took the product to Phase III solo what % on sales is reasonable to expect.
10% or less to me would seem a complete failure to commercialise our products.
Vivagel BV treatment and prevention
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.17M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5684 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 56840 | 1 |
View Market Depth
| Last trade - 09.50am 24/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable